MAP2K7 and cancer: By controlling C-RAF kinase’s phosphorylation, RUVBL1 influences the RAF/MEK/ERK pathway, which is known to be overactivated in several cancer types, including non-small lung carcinoma (NSCLC), leading to cancer progression [7].